Literature DB >> 33477686

Chiral Tertiary Amine Catalyzed Asymmetric [4 + 2] Cyclization of 3-Aroylcoumarines with 2,3-Butadienoate.

Jun-Lin Li1, Xiao-Hui Wang1, Jun-Chao Sun1, Yi-Yuan Peng1, Cong-Bin Ji2, Xing-Ping Zeng1.   

Abstract

Coumarins and 2H-pyran derivatives are among the most commonly found structural units in natural products. Therefore, the introduction of 2H-pyran moiety into the coumarin structural unit, i.e., dihydrocoumarin-fused dihydropyranones, is a potentially successful route for the identification of novel bioactive structures, and the synthesis of these structures has attracted continuing research interest. Herein, a chiral tertiary amine catalyzed [4 + 2] cyclization of 3-aroylcoumarines with benzyl 2,3-butadienoate was reported. In the presence of Kumar's 6'-(4-biphenyl)-β-iso-cinchonine, the desired dihydrocoumarin-fused dihydropyranone products could be obtained in up to 97% yield and 90% ee values.

Entities:  

Keywords:  3-aroylcoumarines; 6’-(4-biphenyl)-β-iso-cinchonine; benzyl 2,3-butadienoate; coumarins; dihydrocoumarin-fused dihydropyranones

Year:  2021        PMID: 33477686      PMCID: PMC7831925          DOI: 10.3390/molecules26020489

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  20 in total

1.  Total synthesis of (±)-δ-rubromycin.

Authors:  Wenjing Wang; Jijun Xue; Tian Tian; Jie Zhang; Liping Wei; Jidong Shao; Zhixiang Xie; Ying Li
Journal:  Org Lett       Date:  2013-05-01       Impact factor: 6.005

2.  Asymmetric Inverse-Electron-Demand Oxa-Diels-Alder Reaction of Allylic Ketones through Dienamine Catalysis.

Authors:  Ming-Lin Shi; Gu Zhan; Su-Lan Zhou; Wei Du; Ying-Chun Chen
Journal:  Org Lett       Date:  2016-12-08       Impact factor: 6.005

Review 3.  A Review on Pharmacological Properties of Coumarins.

Authors:  Devulapally Srikrishna; Chandraiah Godugu; Pramod Kumar Dubey
Journal:  Mini Rev Med Chem       Date:  2018       Impact factor: 3.862

4.  Enantioselective Synthesis of Dihydropyran-Fused Indoles through [4+2] Cycloaddition between Allenoates and 3-Olefinic Oxindoles.

Authors:  Feng Wang; Zhen Li; Jie Wang; Xin Li; Jin-Pei Cheng
Journal:  J Org Chem       Date:  2015-04-29       Impact factor: 4.354

5.  Organocatalytic Friedel-Crafts Alkylation/Lactonization Reaction of Naphthols with 3-Trifluoroethylidene Oxindoles: The Asymmetric Synthesis of Dihydrocoumarins.

Authors:  Yun-Long Zhao; Qin-Xin Lou; Long-Sheng Wang; Wen-Hui Hu; Jun-Ling Zhao
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-30       Impact factor: 15.336

6.  Highly enantioselective synthesis of dihydrocoumarin-fused dihydropyrans via the phosphine-catalyzed [4 + 2] annulation of allenones with 3-aroylcoumarins.

Authors:  Xiaoyu Han; Huanzhen Ni; Wai-Lun Chan; Xikun Gai; Yongjiang Wang; Yixin Lu
Journal:  Org Biomol Chem       Date:  2016-05-13       Impact factor: 3.876

7.  N-heterocyclic carbene-catalyzed [4 + 2] cycloaddition of ketenes and 3-aroylcoumarins: highly enantioselective synthesis of dihydrocoumarin-fused dihydropyranones.

Authors:  Teng-Yue Jian; Xiang-Yu Chen; Li-Hui Sun; Song Ye
Journal:  Org Biomol Chem       Date:  2013-01-07       Impact factor: 3.876

8.  3-Homoacyl coumarin: an all carbon 1,3-dipole for enantioselective concerted (3+2) cycloaddition.

Authors:  Yi-Ru Chen; Madhusudhan Reddy Ganapuram; Kai-Hong Hsieh; Kai-Han Chen; Praneeth Karanam; Sandip Sambhaji Vagh; Yan-Cheng Liou; Wenwei Lin
Journal:  Chem Commun (Camb)       Date:  2018-11-08       Impact factor: 6.222

Review 9.  Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds.

Authors:  Angela Stefanachi; Francesco Leonetti; Leonardo Pisani; Marco Catto; Angelo Carotti
Journal:  Molecules       Date:  2018-01-27       Impact factor: 4.411

Review 10.  Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.

Authors:  Kinga Kasperkiewicz; Michał B Ponczek; Jacek Owczarek; Piotr Guga; Elżbieta Budzisz
Journal:  Molecules       Date:  2020-03-24       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.